![Jeffrey Tong](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Tong
Chairman at
SEPTERNA, INC.
Net worth: - $ as of 2026-09-29
Profile
Jeffrey K.
Tong is currently Executive Chairman at Ambys Medicines, Inc. since 2021.
He is Chairman at Septerna, Inc. since 2021, Director at Asher Biotherapeutics, Inc., Director at Terremoto Biosciences, Inc., and Partner at Third Rock Ventures LLC since 2016.
Former roles include President & Chief Executive Officer at Nora Therapeutics, Inc. from 2010 to 2015, Chief Executive Officer at Marea Therapeutics, Inc., Chairman at Delinia, Inc. from 2016 to 2017, Independent Director at Nurix Therapeutics, Inc. from 2018 to 2022, Independent Director at Maze Therapeutics, Inc., Director at Regeneration NewCo, Inc., Non-Executive Director at Rapport Therapeutics, Inc. in 2024, Consultant at McKinsey & Co., Inc., and Vice President-Corporate & Product Development at Infinity Pharmaceuticals, Inc. Education includes undergraduate degree from Harvard College, graduate and doctorate degrees from Harvard University, and a graduate degree from Harvard Medical School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SEPTERNA, INC. -.--% | 2026-06-25 | 0 ( -.--% ) | - $ | 2026-09-29 |
Jeffrey Tong active positions
| Companies | Position | Start |
|---|---|---|
| SEPTERNA, INC. | Chairman | 2021-10-31 |
Ambys Medicines, Inc.
 Ambys Medicines, Inc. Pharmaceuticals: MajorHealth Technology Develops regenerative medicine therapies for serious liver diseases | Chairman | 2018-12-12 |
Terremoto Biosciences, Inc.
 Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases | Director/Board Member | - |
Asher Biotherapeutics, Inc.
 Asher Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops immunotherapies | Director/Board Member | - |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It provides financing for early stage capital requirements. The firm also acts as lead investor. | Private Equity Investor | 2015-12-31 |
Former positions of Jeffrey Tong
| Companies | Position | End |
|---|---|---|
| RAPPORT THERAPEUTICS, INC. | Director/Board Member | 2024-11-06 |
Regeneration NewCo, Inc.
 Regeneration NewCo, Inc. Financial ConglomeratesFinance Operates as a development stage company | Director/Board Member | 2023-12-28 |
| NURIX THERAPEUTICS, INC. | Director/Board Member | 2022-05-04 |
Delinia, Inc.
 Delinia, Inc. BiotechnologyHealth Technology Develops novel therapeutics for the treatment of autoimmune diseases | Chairman | 2016-12-31 |
Education of Jeffrey Tong
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
75
1st degree connections
16
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 16 |
|---|---|
Nurix Therapeutics, Inc.
 Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Infinity Pharmaceuticals, Inc.
 Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It provides financing for early stage capital requirements. The firm also acts as lead investor. | Finance |
Nora Therapeutics, Inc.
 Nora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides therapeutic treatments for infertility and miscarriages | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Delinia, Inc.
Delinia, Inc. BiotechnologyHealth Technology Develops novel therapeutics for the treatment of autoimmune diseases | Health Technology |
Ambys Medicines, Inc.
Ambys Medicines, Inc. Pharmaceuticals: MajorHealth Technology Develops regenerative medicine therapies for serious liver diseases | Health Technology |
Maze Therapeutics, Inc.
 Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases | Health Technology |
Asher Biotherapeutics, Inc.
Asher Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops immunotherapies | Health Technology |
Regeneration NewCo, Inc.
Regeneration NewCo, Inc. Financial ConglomeratesFinance Operates as a development stage company | Finance |
Septerna, Inc.
 Septerna, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that discovers and develops G protein-coupled receptor oral small molecule products for the treatment of hypoparathyroidism | Health Technology |
Terremoto Biosciences, Inc.
Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases | Health Technology |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Operates as an clinical-stage biotechnology company that engages in discovery and development of medicines for neurological disorder | Health Technology |
- Stock Market
- Insiders
- Jeffrey Tong
